Literature DB >> 24041960

High glucose increases glomerular filtration barrier permeability by activating protein kinase G type Iα subunits in a Nox4-dependent manner.

Agnieszka Piwkowska1, Dorota Rogacka, Irena Audzeyenka, Stefan Angielski, Maciej Jankowski.   

Abstract

Hyperglycemia is a primary factor that disturbs podocyte function in the glomerular filtration process; this disturbance leads to the development of diabetic nephropathy, and ultimately, renal failure. Podocyte function may also be altered by biological agents that modify protein kinase activity, including the cGMP-activated protein kinase type Iα (PKGIα). We hypothesized that hyperglycemia-induced podocyte protein hyperpermeability was dependent on PKGIα activation, and that PKGIα was activated via dimerization induced by reactive oxygen species. This hypothesis was investigated in rat podocytes cultured in high glucose (HG, 30 mM). Protein expression was measured with Western blot and immunofluorescence. Podocyte permeability was measured with a transmembrane albumin flux assay. We found that HG increased podocyte permeability in long-term incubations (1, 3, and 5 days); permeability was increased by 66% on day 5. This effect was abolished with apocynin, a NAD(P)H inhibitor, and Rp-8-Br-cGMPS, a PKG inhibitor. It was also abolished by introducing small interfering RNAs (siRNAs) against Nox4 and PKGIα into cultured podocytes. Furthermore, HG increased PKGIα dimerization by 138% (0.23 ± 0.04 vs. 0.54 ± 0.09; P<0.05); this effect was abolished with a siRNA against Nox4. Our observations suggested that HG could increase albumin permeability across the podocyte filtration barrier via Nox4-dependent PKGIα dimerization.
© 2013 Published by Elsevier Inc.

Entities:  

Keywords:  Filtration barrier permeability; High glucose concentration; NAD(P)H oxidase; Podocyte; Protein kinase G type Iα

Mesh:

Substances:

Year:  2013        PMID: 24041960     DOI: 10.1016/j.yexcr.2013.09.005

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  3 in total

Review 1.  Have dipeptidyl peptidase-4 inhibitors ameliorated the vascular complications of type 2 diabetes in large-scale trials? The potential confounding effect of stem-cell chemokines.

Authors:  Milton Packer
Journal:  Cardiovasc Diabetol       Date:  2018-01-08       Impact factor: 9.951

2.  Concomitant treatment with insulin and sodium-glucose cotransporter 2 inhibitors was associated with the renal composite outcome in Japanese patients with type 2 diabetes and chronic kidney disease: A propensity score-matched analysis.

Authors:  Masao Toyoda; Nobumichi Saito; Moritsugu Kimura; Nobuo Hatori; Kouichi Tamura; Masaaki Miyakawa; Kazuyoshi Sato; Akira Kanamori; Kazuo Kobayashi
Journal:  J Diabetes Investig       Date:  2022-05-20       Impact factor: 3.681

3.  The PKGIα/VASP pathway is involved in insulin- and high glucose-dependent regulation of albumin permeability in cultured rat podocytes.

Authors:  Patrycja Rachubik; Maria Szrejder; Irena Audzeyenka; Dorota Rogacka; Michał Rychłowski; Stefan Angielski; Agnieszka Piwkowska
Journal:  J Biochem       Date:  2020-12-26       Impact factor: 3.387

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.